Axogen Corp - AXGN Company Total Asset Base

Corporate emblem and logo of AxoGen Inc (AXGN)

AxoGen, Inc. (AXGN) generates revenue through the sale of biomaterials and protectors for peripheral nerve regeneration. This chart of the company's price action reflects total assets, which stand at 255.13. Growth in these metrics is driven by the expansion of innovative grafts into reconstructive surgery. Success is further bolstered by an ethical corporate environment and the motivation of the engineering staff through stock option programs and an awareness of the social significance of their developments.

Axogen Corp (AXGN) Company Total Assets: for the period 07/04/2022 - 10/28/2026

Axogen Corp - analytical breakdowns and key metrics (AXGN)

- price and consensus price forecast:
Share Price axogeninc.com|AXGN - Price Target Chart
- market capitalization data:
Market Capitalization Axogen Surgical|AXGN - Total Company Value
- book capitalization data:
Share Book Value Axogen|AXGN - Book Capitalization|Market-to-Book Ratio axogeninc.com|AXGN - Company Total Assets
- debt and liquidity data:
Total Debt to Equity Ratio AxoGen, Inc.|AXGN - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Axogen Surgical|AXGN - Company Aggregate Debts|Debts to Book Capitalization Axogen Surgical
Fundamental valuation:axogeninc.com, AXGN
Manufactured product of AxoGen, Inc.

The scale of AxoGen, Inc. (AXGN) operations in providing clinics with neurosurgical solutions is reflected in the total value of business resources, which the history of balance sheet assets calculates reversely via ROA to separate the real value of property from market speculation. This methodology allows an investor to assess the actual efficiency of capital and liability management, confirming the company's fundamental resilience to external shocks regardless of price volatility.

Main competitors

BSX (bostonscientific.com) - Total Business Assets|EW: Aggregate Company Assets|Company Total Asset Base RMD|PODD - Aggregate Company Assets|Total Asset Value of Company Zimmer Biomet Holdings Inc (ZBH)|COO: Company Total Assets|Company Assets aligntech.com ALGN|GMED: Company Total Assets|TMDX - Cumulative Company Assets|ATEC Spine - Company Total Assets|Artivion Corp (AORT) - Company Total Asset Base|ENOV (Enovis Corporation) - Company Total Assets|Company Total Assets IART|Aggregate Company Assets Establishment Labs Holdings Inc. (ESTA)|Aggregate Company Assets Beta Bionics, Inc. (BBNX)|Company Total Assets IRMD|EMBC - Company Total Asset Base|Cumulative Company Assets Tandem Diabetes Care|SIBN - Total Asset Value of Company|Company Total Assets OFIX|Bioventus Inc (BVS) - Company Assets|Company Total Assets OrthoPediatrics Corp (KIDS)|Total Business Assets Treace Corp (TMCI)|Strata Critical Medical Inc (SRTA) - Cumulative Company Assets|Aggregate Asset Value CARL (carlsmed.com)|RxSight - Aggregate Company Assets|Cumulative Company Assets ClearPoint Neuro Inc. CLPT|STXS (Stereotaxis Corp) - Company Total Assets|STIM - Company Assets|Company Total Assets Sight Sciences, Inc.|orchestrabiomed.com (OBIO) - Total Business Assets|ANIK: Company Total Assets|Company Total Asset Base InspireMD Inc|Company Total Assets ZJYL (Jin Medical International)|Cumulative Company Assets vivani.com (VANI)|Company Total Assets XTNT (Xtant Medical)|n1mtc.com - Company Total Assets|MODD - Aggregate Company Assets|Myomo Inc. (MYO) - Aggregate Company Assets|Cumulative Company Assets Envoy Medical, Inc COCH|Vivos Therapeutics Inc (VVOS) - Aggregate Asset Value|Company Total Assets NVNO (enVVeno Medical)|Company Assets SINT|TNON: Aggregate Company Assets|Company Balance Sheet Assets ReWalk Robotics LFWD|Cumulative Company Assets AMIX (Autonomix Medical)|Company Total Assets INVO Fertility Corp IVF|Company Total Assets BBLG (Bone Biologics)|AXNX: Company Total Asset Base|Aggregate Company Assets BIOLASE (BIOL)|DYNT (Dynatronics) - Total Asset Value of Company|Aggregate Company Assets FNA|Cumulative Company Assets INVO Bio